Ocular Therapeutix Inc
NASDAQ:OCUL
Balance Sheet
Balance Sheet Decomposition
Ocular Therapeutix Inc
Current Assets | 519.8m |
Cash & Short-Term Investments | 482.9m |
Receivables | 26.5m |
Other Current Assets | 10.4m |
Non-Current Assets | 19.1m |
PP&E | 17.5m |
Other Non-Current Assets | 1.6m |
Current Liabilities | 24.3m |
Accounts Payable | 6.5m |
Accrued Liabilities | 17.6m |
Other Current Liabilities | 263k |
Non-Current Liabilities | 106.7m |
Long-Term Debt | 66.5m |
Other Non-Current Liabilities | 40.2m |
Balance Sheet
Ocular Therapeutix Inc
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
37
|
31
|
33
|
42
|
54
|
54
|
228
|
164
|
102
|
196
|
|
Cash Equivalents |
37
|
31
|
33
|
42
|
54
|
54
|
228
|
164
|
102
|
196
|
|
Short-Term Investments |
37
|
74
|
35
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Receivables |
0
|
0
|
0
|
0
|
0
|
3
|
12
|
21
|
21
|
26
|
|
Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
3
|
12
|
21
|
21
|
26
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
|
Other Current Assets |
1
|
2
|
1
|
2
|
2
|
2
|
5
|
5
|
4
|
8
|
|
Total Current Assets |
76
|
107
|
70
|
43
|
56
|
60
|
246
|
191
|
130
|
232
|
|
PP&E Net |
2
|
3
|
3
|
11
|
10
|
17
|
14
|
12
|
18
|
18
|
|
PP&E Gross |
2
|
3
|
3
|
11
|
10
|
17
|
14
|
12
|
18
|
18
|
|
Accumulated Depreciation |
2
|
3
|
4
|
5
|
8
|
10
|
13
|
15
|
17
|
20
|
|
Other Long-Term Assets |
0
|
0
|
2
|
2
|
7
|
2
|
2
|
2
|
2
|
2
|
|
Total Assets |
78
N/A
|
110
+41%
|
75
-32%
|
55
-26%
|
73
+32%
|
79
+8%
|
262
+233%
|
205
-22%
|
149
-27%
|
252
+69%
|
|
Liabilities | |||||||||||
Accounts Payable |
1
|
2
|
2
|
4
|
3
|
3
|
3
|
5
|
5
|
4
|
|
Accrued Liabilities |
3
|
3
|
5
|
4
|
6
|
9
|
16
|
22
|
26
|
30
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
1
|
0
|
2
|
6
|
0
|
0
|
8
|
0
|
0
|
0
|
|
Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
Total Current Liabilities |
6
|
5
|
8
|
13
|
9
|
12
|
27
|
26
|
31
|
35
|
|
Long-Term Debt |
14
|
15
|
14
|
13
|
25
|
49
|
41
|
51
|
54
|
75
|
|
Other Liabilities |
0
|
0
|
1
|
3
|
3
|
21
|
118
|
39
|
29
|
51
|
|
Total Liabilities |
20
N/A
|
21
+6%
|
23
+11%
|
29
+28%
|
37
+27%
|
82
+122%
|
186
+125%
|
117
-37%
|
114
-3%
|
161
+41%
|
|
Equity | |||||||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
89
|
129
|
174
|
237
|
297
|
384
|
539
|
546
|
617
|
698
|
|
Additional Paid In Capital |
148
|
219
|
226
|
263
|
333
|
380
|
615
|
634
|
652
|
789
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Equity |
59
N/A
|
90
+53%
|
52
-42%
|
26
-50%
|
36
+38%
|
4
N/A
|
76
N/A
|
88
+16%
|
35
-60%
|
91
+157%
|
|
Total Liabilities & Equity |
78
N/A
|
110
+41%
|
75
-32%
|
55
-26%
|
73
+32%
|
79
+8%
|
262
+233%
|
205
-22%
|
149
-27%
|
252
+69%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
21
|
25
|
25
|
30
|
42
|
50
|
76
|
77
|
77
|
115
|